FDG PET/CT in the Management of Nasopharyngeal Carcinoma

被引：39

作者：

Mohandas, Aravind ^{[1
]}

Marcus, Charles ^{[1
]}

Kang, Hyunseok ^{[2
]}

Truong, Minh-Tam ^{[3
]}

Subramaniam, Rathan M. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 601 N Caroline St,JHOC 3235, Baltimore, MD 21287 USA

[2] Johns Hopkins Sch Med, Dept Med Oncol, Baltimore, MD 21287 USA

[3] Boston Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02118 USA

[4] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA

[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2014年 / 203卷 / 02期

关键词：

nasopharyngeal cancer; patient outcome; PET/CT; radiation therapy planning; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; BARR-VIRUS DNA; METABOLIC TUMOR VOLUME; INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; F-18-FDG PET; COMPUTED-TOMOGRAPHY; DISTANT METASTASIS; CT;

D O I：

10.2214/AJR.13.12420

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences. CONCLUSION. FDG PET/CT is a valuable imaging test in the management of NPC.

引用

页码：W146 / W157

页数：12

共 55 条

[1] Evolving Role of FDG PET/CT in Multiple Myeloma Imaging and Management
Agarwal, Ankit
Chirindel, Alin
Shah, Bhartesh A.
Subramaniam, Rathan M.
[J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 200 (04) : 884 - 890
[2] Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
Al-Sarraf, M
LeBlanc, M
Giri, PGS
Fu, KK
Cooper, J
Vuong, T
Forastiere, AA
Adams, G
Sakr, WA
Schuller, DE
Ensley, JF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1310 - 1317
[3] [Anonymous], 2013, NCCN Clinical Practice Guidelines in Oncology: Survivorship
[4] Barnes L., 2005, World Health Organisation classification of tumours. Pathology and genetics of tumours of the head and neck
[5] Prediction of surgical outcome using plasma epstein-barr virus dna and 18F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma
Chan, Jimmy Yu Wai
Chow, Velda Ling Yu
Mok, Vivian Way Kay
Ho, Ambrose Chung Wai
Wei, William Ignace
[J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (04): : 541 - 545
[6] Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma:: comparison with magnetic resonance imaging
Chan, Sheng-Chieh
ng, Shu-Ha Ng
Chang, Joseph Tung-Chieh
Lin, Chien-Yu
Chen, Yen-Chao
Chang, Yu-Chen
Hsu, Cheng-Lung
Wang, Hung-Ming
Liao, Chun-Ta
Yen, Tzu-Chen
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (09) : 1032 - 1040
[7] Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Chan, Sheng-Chieh
Kuo, Wen-Han
Wang, Hung-Ming
Chang, Joseph Tung-Chieh
Lin, Chien-Yu
Ng, Shu-Hang
Hsu, Cheng-Lung
Chang, Kai-Ping
Liao, Chun-Ta
Lin, Yu-Jr
Yen, Tzu-Chen
[J]. ANNALS OF NUCLEAR MEDICINE, 2013, 27 (08) : 710 - 719
[8] The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma
Chan, Sheng-Chieh
Hsu, Cheng-Lung
Yen, Tzu-Chen
Ng, Shu-Hang
Liao, Chun-Ta
Wang, Hung-Ming
[J]. ORAL ONCOLOGY, 2013, 49 (01) : 71 - 78
[9] Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification
Chan, Winnie K. S.
Mak, Henry K. F.
Huang, Bingsheng
Yeung, David W. C.
Kwong, Dora Lai-Wan
Khong, Pek-Lan
[J]. NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 206 - 210
[10] Chang KP, 2012, J NUCL MED, V53, P342

← 1 2 3 4 5 6 →